Lentiviral vectors for immune cells targeting.

Area of Science:

• Gene Therapy
• Molecular Biology
• Immunology

Background:

• Lentiviral vectors (LVs) are effective for long-term transgene expression across diverse cell types.
• Targeting LVs to specific cells is crucial for advancing their clinical translation.
• Immune system cells are key targets for lentiviral vector-mediated gene therapy.

Purpose of the Study:

• To provide an overview of innovative strategies for targeting lentiviral vectors to immune cells.
• To discuss two primary approaches for achieving targeted gene delivery using LVs.

Main Methods:

• Review of LV surface modifications for cell-specific vector targeting.
• Analysis of tissue-specific promoters for controlling transgene transcription.
• Discussion of strategies combining vector surface engineering and transcriptional control.

Main Results:

• LV surface modifications enable direct targeting of specific cell populations.
• Tissue-specific promoters regulate transgene expression within desired cell types.
• Combined targeting strategies offer potential for reduced off-target effects.

Conclusions:

• Both LV surface targeting and promoter-driven expression are valuable strategies.
• Integrating these approaches can significantly improve LV safety and therapeutic efficiency.
• Targeted lentiviral vectors hold promise for enhanced gene therapy applications.